SMN reported $624K of EBITDA for the March quarter, annualized this becomes $2.496 million.
For the exercise, if you consider this number to be annual earnings then based on a P/E of 30, the share price would be about $0.54.
Continued increases in profit from A.E.M. would start to make the stock more appealing with the added bonus of potential CVM approval.
Ann: An Update from the Executive Chairman, page-131
Add SMN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.030(7.69%) |
Mkt cap ! $57.45M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 42.0¢ | 39.0¢ | $22.26K | 55.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 843 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 25000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
39.5¢ |
Change
0.030 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 39.5¢ | 40.0¢ | 39.5¢ | 6629 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| SMN (ASX) Chart |